(Q38498399)

3 September 2017

title

IL-12 is produced by antigen-presenting cells stimulated with soluble alphabeta TCR and restores impaired T(h)1 responses (English)

1 reference

3 September 2017

Kawamoto K

1

1 reference

3 September 2017

Paliwal V

2

1 reference

3 September 2017

Ramabhadran R

3

1 reference

3 September 2017

Szczepanik M

4

1 reference

3 September 2017

Tsuji RF

5

1 reference

3 September 2017

Matsuda H

6

1 reference

3 September 2017

Askenase PW

7

1 reference

3 September 2017

publication date

1 January 2000

1 reference

3 September 2017

published in

International Immunology

1 reference

3 September 2017

volume

12

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

103-112

1 reference

Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Antigen-specific T lymphocyte clones. I. Characterization of a T lymphocyte clone expressing antigen-specific suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Recombinant interleukin 12 cures mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Identification and induction of human keratinocyte-derived IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

Physiological enzymatic cleavage of leukocyte membrane molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.1.103

21 January 2018

Identifiers

DOI

10.1093/INTIMM/12.1.103

1 reference

3 September 2017

1 reference